Tip Optofluidic Immunoassay Delivers Immune Profile with One Drop of Blood
Researchers have developed the Tip Optofluidic Immunoassay (TOI), a portable diagnostic platform that assesses COVID-19 antibody protection.
Researchers have developed the Tip Optofluidic Immunoassay (TOI), a portable diagnostic platform that assesses COVID-19 antibody protection.
CovarsaDx supported OSANG Healthcare in securing FDA clearance for the QuickFinder COVID-19/Flu Antigen Self-Test and Pro Test.
The AMP published a consensus report on best practices for SARS-CoV-2 genomic surveillance using next-generation sequencing (NGS).
A new study found routine lab tests may not effectively diagnose long COVID, underscoring the need for new biomarkers and diagnostic tools.
Read MoreResearchers have developed a bioelectric device using biomembranes to quickly detect and classify harmful variants of coronavirus.
Read MoreWatmind USA received FDA Emergency Use Authorization for its rapid OCT SpeedySwab Covid + FLU A&B Self-Test.
Read MoreA new study found that at-home antibody tests can effectively detect inadequate COVID immunity, aiding decisions about booster vaccinations.
Read MoreThe FDA warned against using Cue Health’s COVID tests due to modifications that reduced test reliability and increased risk of false results.
Read MoreiHealth Labs received FDA Emergency Use Authorization for its COVID-19/Flu A&B Rapid Test Kit, enabling quick self-testing at home.
Read MoreThe lab-developed test will help diagnose Long COVID and is aimed to provide accurate insights into personalized treatment approaches.
Read MoreThe COVID test is cleared for those aged 14 or older when self-testing, and those aged two and older when administered by an adult.
Read MoreResearchers have discovered a potential way to predict which patients are likely to suffer long-haul COVID and associated lung problems.
Read MoreResearchers found that proteins regulating plasminogen-plasmin levels can be used as biomarkers to identify those at risk or severe COVID.
Read MoreAnalysis of blood samples from patients with Long COVID has revealed serum protein changes as the likely culprit.Â
Read MoreUsing a molecule found in crustaceans, researchers developed a rapid approach that detects COVID comparably to one used in vaccine research.
Read MoreMaximBio received a $49.5 million award to help fortify their domestic manufacturing capabilities for potential future pandemic preparedness.
Read MoreThis research aims to improve the understanding of how maternal antibodies against SARS-CoV-2 are transferred to and persist in newborns.
Read MoreSekisui formalized an exclusive distribution agreement with Aptitude Medical Systems to sell the Aptitude Metrix COVID Test in the U.S.Â
Read More